| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/15/2000 | US6025545 Reproducible system for the production of stable, genetically transformed maize cells, and to methods of selecting cells that have been transformed |
| 02/15/2000 | US6025544 Use of dna molecules encoding sucrose carriers for modifying plant flowering behavior |
| 02/15/2000 | US6025543 Seed plants exhibiting early reproductive development and methods of making same |
| 02/15/2000 | US6025539 IL-5 transgenic mouse |
| 02/15/2000 | US6025485 Methods and compositions for peptide libraries displayed on light-emitting scaffolds |
| 02/15/2000 | US6025484 Protein D--an IgD-binding protein ofhaemophilus influenzae |
| 02/15/2000 | US6025483 Maize and cauliflower apetalai gene products and nucleic acid molecules encoding same |
| 02/15/2000 | US6025480 Isolated nucleic acid molecules encoding P57KIP2 |
| 02/15/2000 | US6025477 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 02/15/2000 | US6025475 Antibody |
| 02/15/2000 | US6025474 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 02/15/2000 | US6025473 Nucleic acid which encodes a protein which can confer multidrug resistance on a drug sensitive mammalian cell when expressed in the cell and which is overexpressed in certain multidrug resistant cancer cell lines |
| 02/15/2000 | US6025469 Murine UCP3 polypeptides |
| 02/15/2000 | US6025468 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides |
| 02/15/2000 | US6025467 Parathyroid hormone derivatives and their use |
| 02/15/2000 | US6025465 Insulin-like growth factor binding protein (IGFBP-6) |
| 02/15/2000 | US6025464 Two new WD-40 proteins |
| 02/15/2000 | US6025342 Analog of Haemophilus Hin47 with reduced protease activity |
| 02/15/2000 | US6025341 Chimeric hepatitis B/hepatitis C virus vaccine |
| 02/15/2000 | US6025340 Surface expression of enzyme in gene directed prodrug therapy |
| 02/15/2000 | US6025338 Nucleic acid vaccines against rickettsial diseases and methods of use |
| 02/15/2000 | US6025333 Treatment of CNS tumors with metalloprotease inhibitors |
| 02/15/2000 | US6025331 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis |
| 02/15/2000 | US6025330 Inhibitors of fibrin cross-linking and/or transglutaminases |
| 02/15/2000 | US6025329 Method for treating ophthalmic diseases |
| 02/15/2000 | US6025327 Derived from chicken sternal cartilage; treating cartilage defects; nutritional supplement |
| 02/15/2000 | US6025325 Pegylated obese (ob) protein compositions |
| 02/15/2000 | US6025204 Diagnostic method for detection of placental-derived prostate growth factors |
| 02/15/2000 | US6025197 Secreted salivary zsig32 polypeptides |
| 02/15/2000 | US6025196 Chimeric proteins comprising liver enriched transcription factors and nucleic acids encoding the same |
| 02/15/2000 | US6025195 Liver-specific adenovirus expression vector |
| 02/15/2000 | US6025192 Modified retroviral vectors |
| 02/15/2000 | US6025191 For diagnosis, immunotherapy, gene therapy and anticarcinogenic agents |
| 02/15/2000 | US6025175 Amino acid sequence; for screening new bactericides and bacteristats to treat otitis media, conjunctivitis, pneumonia, bacteremia, meningitis, sinusitis, pleural empyema and endocarditis; diagnosis of infections |
| 02/15/2000 | US6025166 Human trk receptors and neurotrophic factor inhibitors |
| 02/15/2000 | US6025164 Bacterial antigens and vaccine compositions |
| 02/15/2000 | US6025163 DNA coding for a peptide of a papilloma virus main capside protein and use thereof |
| 02/15/2000 | US6025162 Nucleic acid encoding an amino acid sequence of protein; for diagnosis and treatment of allergies |
| 02/15/2000 | US6025161 Introducing vector comprising a mammalian antitrypsin dna sequence into a host cell, culturing cell, then isolating product |
| 02/15/2000 | US6025160 Polynucleotide and polypeptide sequences encoding rat mdr1b2 and screening methods thereof |
| 02/15/2000 | US6025159 Nucleotide sequence from trigonopsis variabilis; for increased expression of heterologous genes in host systems by replacing promoter of selectable marker, leading to amplification of the plasmid |
| 02/15/2000 | US6025157 Neurturin receptor |
| 02/15/2000 | US6025154 Amino acid sequence; for anticarcinogenic/antitumor agents, wound healing agents; parasiticides; antiinflammatory/ antiarthritic agents; treatment of autoimmune diseases, allergic reactions, shock, chronic infections, psoriasis |
| 02/15/2000 | US6025150 Methods and compositions for wound healing |
| 02/15/2000 | US6025145 Sensitive, reliable immunoassay using eukaryotic cells expressing receptor construct comprising flag polypeptide and tyrosine kinase receptor, exposing to ligand, lysing cells and measuring phosphotyrosine |
| 02/15/2000 | US6025144 Immunoassay test kit for measuring bone resorption |
| 02/15/2000 | US6025143 Purified monoclonal or polyclonal antibody against a peptide having specific amino acid sequence from a gene controlled by andogens and isolated from submaxillary gland of the rat; for diagnosis, detection and therapeutics |
| 02/15/2000 | US6025141 Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form |
| 02/15/2000 | US6025140 Membrane-permeable constructs for transport across a lipid membrane |
| 02/15/2000 | US6025138 Method for detecting the presence of a polynucleotide encoding a hyaluronan receptor expressed in human umbilical vein endothelial cells |
| 02/15/2000 | US6025137 Exposing test sample under high stringency conditions to an isolated nucleic acid that hybridizes to fohy030 messenger rna; rna is from gene which is expressed at a higher level in benign, non-metastatic tumors than in malignant tumors |
| 02/15/2000 | US6025130 Nucleotide sequence of gene; for screening of homozygotes, diagnosis, and prenatal screening using oligonucleotide primers |
| 02/15/2000 | US6025127 Diagnosing metastasis by analyzing tumor margin, chyle, blood or a local lymph node, having normal morphology; amplifying sample nucleic acids using specific oligonucleotides then detecting presence of nucleic acid; accurate staging |
| 02/15/2000 | US6025125 Methods for the detection of HIV-specific immune responses employing non-infectious, non-replicating, IIV retrovirus-like particles containing heterologous antigenic markers |
| 02/15/2000 | US6024966 Gene encoding protein antigens of plasmodium falciparum and uses therefor |
| 02/15/2000 | US6024965 Immunology for treatment of aids and t-cell epitopes |
| 02/15/2000 | US6024962 Mercaptan gene and amine terminus with amine acid nucleic acid sequence |
| 02/15/2000 | US6024958 Polypeptide fragments capable of competition with Streptococcus mutans antigen I/II |
| 02/15/2000 | US6024955 Peptide with amino acid sequences |
| 02/15/2000 | US6024953 Prevention of rabies in mammals, administering a hybrid vaccine |
| 02/15/2000 | US6024936 Antibody-based method of localizing activated thrombin receptors |
| 02/15/2000 | CA2223460C Induction of male sterility in plants by expression of high levels of avidin |
| 02/15/2000 | CA2168552C Refolding of polypeptides like recombinant insulin-like growth factor igf-1 |
| 02/15/2000 | CA2132001C Methods of treating cancer using modified c-reactive protein |
| 02/15/2000 | CA2015994C Human lactoferrin cdna sequence |
| 02/15/2000 | CA2004478C Monoclonal antibodies to feline-t-lymphotropic lentivirus |
| 02/15/2000 | CA1340900C Method for indentifying and using biosynthetic or regulatory genes for enhanced production of secondary metabolites |
| 02/15/2000 | CA1340899C Procede de preparation de complexes nitruro 99m tc, 186 re ou 188 re utilisables comme produits radiopharmaceutiques |
| 02/15/2000 | CA1340896C Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins |
| 02/14/2000 | CA2245224A1 Chemokine receptor antagonists and chemotherapeutics |
| 02/12/2000 | CA2248989A1 Novel compounds |
| 02/10/2000 | WO2000007014A2 Leptin-mediated gene-induction |
| 02/10/2000 | WO2000006772A1 Mutations in and genomic structure of herg - a long qt syndrome gene |
| 02/10/2000 | WO2000006768A1 Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases |
| 02/10/2000 | WO2000006763A1 Fusion products containing insoluble proteinaceous tag |
| 02/10/2000 | WO2000006759A2 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same |
| 02/10/2000 | WO2000006754A2 Engineering nematode resistance in solanacae |
| 02/10/2000 | WO2000006753A1 Engineering nematode resistance in solanacae |
| 02/10/2000 | WO2000006751A2 Repressor proteins producing cell lines for the propagation of vectors |
| 02/10/2000 | WO2000006745A1 Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine |
| 02/10/2000 | WO2000006744A1 Granulocytic ehrlichia genes and uses thereof |
| 02/10/2000 | WO2000006743A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006742A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006741A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006740A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006739A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006738A2 NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 02/10/2000 | WO2000006737A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 02/10/2000 | WO2000006736A2 Nucleic acids and proteins from group b streptococcus |
| 02/10/2000 | WO2000006735A1 Interferon alpha hybrids |
| 02/10/2000 | WO2000006734A1 Chondrogenic and osteogenic inducing molecule |
| 02/10/2000 | WO2000006733A2 T cell receptor proteins, nucleic acid molecules, and uses thereof |
| 02/10/2000 | WO2000006732A2 Polynucleotide encoding an autoantigen associated with endometriosis |
| 02/10/2000 | WO2000006731A2 PERSEPHIN ARF, A PROTEIN ENCODED BY UNSPLICED PERSEPHIN mRNA |
| 02/10/2000 | WO2000006730A2 Human cytoskeletal proteins |
| 02/10/2000 | WO2000006729A1 Kdel receptor inhibitors |
| 02/10/2000 | WO2000006728A2 Phosphorylation effectors |
| 02/10/2000 | WO2000006727A2 Human epidermal proteins hepi-1 to hepi-6 |
| 02/10/2000 | WO2000006726A2 Delta-related polypeptides |
| 02/10/2000 | WO2000006724A1 Remedies for neuropathy containing as the active ingredient galectin-1 or its derivatives |